Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
zolpidem tartrate
|
| gptkbp:approvedBy |
gptkb:FDA
2009 |
| gptkbp:ATCCode |
N05CF02
|
| gptkbp:brand |
gptkb:zolpidem
|
| gptkbp:broadcastOn |
Schedule IV (US)
|
| gptkbp:contraindication |
severe hepatic impairment
hypersensitivity to zolpidem |
| gptkbp:drugClass |
sedative-hypnotic
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Edluar
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Meda_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
GABA-A receptor agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
sublingual
|
| gptkbp:sideEffect |
dizziness
headache drowsiness |
| gptkbp:usedFor |
treatment of insomnia
|
| gptkbp:bfsParent |
gptkb:zolpidem
|
| gptkbp:bfsLayer |
6
|